|
|
 |
GIAPREZA Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
FD&C RED NO. 3 Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
GATTEX KIT Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
ETHYLCELLULOSE Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|